Table 3

 Results from nine patients with idiopathic restless legs syndrome

VASPLMW/h
Mean (SEM)Relative reduction of symptoms (%)p Value (v baseline)Mean (SEM)Relative reduction of symptoms (%)p Value (v baseline)
Values are given as mean (SEM) and relative reduction of symptoms as compared with baseline. Visual analogue sale (VAS) and periodic leg movements per hour (PLMW/h) under the four conditions of baseline, apomorphine, apomorphine + naloxone, and apomorphine + metoclopramide.
Baseline5.8 (0.7)56.4 (19.2)
Apomorphine2.6 (0.8)−54.50.0111.1 (1.1)−98.00.012
Apomorphine + naloxone3.1 (0.8)−46.40.0150.9 (0.6)−98.40.012
Apomorphine + metoclopramide3.4 (0.8)−41.70.02814.2 (8.3)−74.80.058